Johan Giléus — CFO

Get alerts when Johan Giléus trades

Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: Alligator Bioscience AB.

12-month summary

No open-market buys or sales in the last 12 months

0 open-market buys, 0 sales, 0 share awards

Roles

15.09.2025 – 18.09.2026

Transactions (including via associated entities)

DateIssuerTransaction typeVolumePriceValueSource
18.09.2026Alligator Bioscience AB Stockholm
New shares (subscription)
via Giléus Invest AB
5,500,000SEK 0.04
SEK 220,000.00
↗
18.09.2026Alligator Bioscience AB Stockholm
Option exercise
via Giléus Invest AB
5,500,000—
No cash value
5,500,000 units
↗
19.03.2026Alligator Bioscience AB Stockholm
Option exercise
via Giléus Invest AB
350,000SEK 0.20
SEK 70,000.00
↗
19.03.2026Alligator Bioscience AB Stockholm
Option exercise
via Giléus Invest AB
350,000—
No cash value
350,000 units
↗
22.12.2025Alligator Bioscience AB Stockholm
New shares (subscription)
via Giléus Invest AB
350,000SEK 0.40
SEK 140,000.00
↗
22.12.2025Alligator Bioscience AB Stockholm
Option exercise
via Giléus Invest AB
350,000—
No cash value
350,000 units
↗
15.09.2025Alligator Bioscience AB Stockholm
Option exercise
via Giléus Invest AB
10,000SEK 3.12
SEK 31,200.00
↗
15.09.2025Alligator Bioscience AB Stockholm
Option exercise
via Giléus Invest AB
10,000,000—
No cash value
10,000,000 units
↗